Safinamide mesylate
| CAS No. | 202825-46-5 | Cat. No. | BCP16018 |
| Name | Safinamide mesylate | ||
| Synonyms | Safinamide mesilate;NW 1015; PNU 151774E; PNU-151774E; EMD 1195686; FCE-28073; FCE28073; FCE 28073; | ||
| Formula | C17H19FN2O2.CH4O3S | M. Wt | 398.45 |
| Description | Safinamide mesylate is a third-generation reversible MAO-B inhibitor, which also blocks sodium voltage-sensitive channels and modulates stimulated release of glutamate. Safinamide was recently licensed by EMA for the treatment of PD as add-on therapy to a stable dose of levodopa alone or in combination with other PD medicinal products in mid-to advanced-stage fluctuating patients. | ||
| Pathways | Neuro Signaling Pathway | ||
| Targets | Monoamine Oxidase | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.